Katherine Elaine Fero, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fero’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A161430 · Current
Licensed to practise in California · since 2019 · expires 2027-03-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$54,453
Pharmacies billed $54,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (23 of 442) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
402 generic and 40 brand-name prescriptions · $54,453 in drug cost · 134 antibiotic prescriptions to 101 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 31 | $14,611 | $471 |
| Mirabegron Er | 25 | $5,833 | $233 |
| Tamsulosin | 58 | $703 | $12 |
| Finasteride | 33 | $517 | $16 |
| Ciprofloxacin | 61 | $411 | $7 |
See all 11 drugs
| Myrbetriq | 31 | $14,611 | $471 |
| Mirabegron Er | 25 | $5,833 | $233 |
| Tamsulosin | 58 | $703 | $12 |
| Finasteride | 33 | $517 | $16 |
| Ciprofloxacin | 61 | $411 | $7 |
| Cephalexin | 32 | $375 | $12 |
| Tadalafil | 26 | $371 | $14 |
| Oxybutynin Chloride | 23 | $173 | $8 |
| Oxycodone | 23 | $148 | $6 |
| Ibuprofen | 14 | $111 | $8 |
| Sulfamethoxazole-Trimethoprim | 14 | $87 | $6 |
Year by year
| 2024 | 442 | 191 | 5% (23) | 9% | $54,453 |
| 2023 | 59 | 36 | 20% (12) | None | $6,389 |
| 2022 | 138 | 80 | 25% (34) | 9% | $11,541 |
| 2021 | 108 | 62 | 15% (16) | 25% | $17,332 |
| 2020 | 100 | 38 | None | 27% | $16,520 |
| 2019 | 14 | 13 | 0% (0) | 0% | $194 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Tamsulosin | 13 | $296 | $23 |
2022: 4 drugs
| Ciprofloxacin | 17 | $80 | $5 |
| Sulfamethoxazole-Trimethoprim | 18 | $79 | $4 |
| Hydrocodone-Acetaminophen | 18 | $74 | $4 |
| Oxycodone | 16 | $67 | $4 |
2021: 3 drugs
| Myrbetriq | 18 | $10,922 | $607 |
| Sulfamethoxazole-Trimethoprim | 14 | $76 | $5 |
| Hydrocodone-Acetaminophen | 12 | $28 | $2 |
2020: 3 drugs
| Myrbetriq | 26 | $14,278 | $549 |
| Tamsulosin | 20 | $247 | $12 |
| Amoxicillin | 12 | $56 | $5 |
Money from drug and device companies
$475 in 2023
| 2023 | 2 | 4 | None | $475 |
| 2022 | 1 | 2 | None | $134 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| UroGen Pharma | Jelmyto | $324 | 3 payments
|
| Boston Scientific | None | $151 | 1 payment
|
See all 4 published payments
| UroGen Pharma | Meals · 2023-08-03 | Jelmyto | $147 |
| UroGen Pharma | Meals · 2023-04-18 | Jelmyto | $158 |
| UroGen Pharma | Meals · 2023-03-04 | Jelmyto | $19 |
| Boston Scientific | Grant · 2023-01-27 | None | $151 |
See earlier years (2022)
2022: $134
| Boston Scientific | Ams Ambicor | $134 | 2 payments
|
Professional record
- NPI
- 1972034825
- Licence
- CA A161430California A161430: Current · expires 2027-03-31
- Trained
- University of California, San Diego School of Medicine, 2017
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 250 Hospital Pkwy, San Jose, CA, 95119
- NPI first listed
- 2017-03-22
- NPI last updated
- 2023-09-08
- NPI record certified
- 2023-09-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.